ADGRL3 and attention deficit-hyperactivity disorder: Functional studies have demonstrated that LPHN3 variants were expressed mainly within brain regions associated with attention and activity (such as PFC, caudate, hippocampus, amygdala, and cerebellum) and were implicated in both ADHD development and pharmacogenetics [150,151].